// App-Quantinova.ai

AB0989 : TUBERCULOSIS RISK IN CHILDREN WITH RHEUMATIC DISEASES TREATED WITH BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS

Researchers

Presenter

  • C. Kavadichanda

Principal Investigators

  • A. M B

  • S. Ajmani

  • I. Maccora

  • S. Balan

  • A. Ramanan

  • V. Agarwal

  • L. Gupta

Medical Centers

  • Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Puducherry, India

  • Arthritis and Rheumatology Clinic, New Delhi, India

  • University of Bristol, Bristol, United Kingdom

  • Aims, Ernakulam, India

  • Bristol Royal Hospital for Children, Bristol, United Kingdom

  • Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India

Locations

  • India

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Tuberculosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved